These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29064177)

  • 1. MicroRNA 499 gene expression in patients on hemodialysis with cardiovascular complications.
    El Sharkawy M; Aly O; Elsayed H; Ezzat H; Mohab A; Usama D
    Hemodial Int; 2017 Oct; 21 Suppl 2():S16-S21. PubMed ID: 29064177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
    Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids.
    de Gonzalo-Calvo D; Martínez-Camblor P; Bär C; Duarte K; Girerd N; Fellström B; Schmieder RE; Jardine AG; Massy ZA; Holdaas H; Rossignol P; Zannad F; Thum T
    Theranostics; 2020; 10(19):8665-8676. PubMed ID: 32754270
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) gene expression in chronic kidney disease patients on hemodialysis: relation to hemodialysis-related cardiovascular morbidity and mortality.
    Elsayed ET; Nassra RA; Naga YS
    Int Urol Nephrol; 2017 Oct; 49(10):1835-1844. PubMed ID: 28550474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR.
    García Moreira V; de la Cera Martínez T; Gago González E; Prieto García B; Alvarez Menéndez FV
    Clin Chem Lab Med; 2006; 44(12):1410-5. PubMed ID: 17163815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
    Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penultimate pulse wave velocity, better than baseline pulse wave velocity, predicted mortality in Italian ESRD cohort study - a case for daily hemodialysis for ESRD patients with accelerated pulse wave velocity changes.
    Onuigbo M; Onuigbo N; Bellasi A; Russo D; Di Iorio BR
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
    Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
    Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria.
    Ajala MO; Ogunro PS; Odun A
    Niger J Clin Pract; 2011; 14(2):154-8. PubMed ID: 21860130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.